Autologous Stem Cell Transplantation for Progressive Systemic Sclerosis
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Autologous Stem Cell Transplantation
- Cardiac Involvement
- Scleroderma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01895244
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Joerg C Henes, MD University Hospital Tuebingen, Department of oncology, hematology, rheumatology
Get Well Soon